A staff member tests samples of the COVID19

Tip Căutare

Id foto

Perioada / Data

De la:

Până la:

Locatie

Autor / editor

Credit

COD GALBEN: 24-04-2025 ora 10 Intre 24 aprilie, ora 12 – 24 aprilie, ora 21 se va semnala instabilitate atmosferică temporar accentuată

Home /
Detaliu foto 13665489

Click pe fotografie pentru a o mari

Titlu: A staff member tests samples of the COVID19

Descriere: (200414) -- BEIJING, April 14, 2020 (Xinhua) -- A staff member tests samples of the COVID-19 inactivated vaccine at a laboratory of Sinovac Biotech Ltd., in Beijing, capital of China, March 16, 2020. China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday.\r\n The two vaccine candidates were developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm), and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical trials of the two vaccines have started. (Xinhua/Zhang Yuwei)

Cuvinte cheie: wn, jt, ncp

ID fotografie: 13665489

Autor: Zhang Yuwei

Credit:

Redactor: Xinhua

Locatie: Beijing - CHINA

Dimensiune: 4332 x 2888 px

Realizat: 2020-03-16

Introdus: 2020-04-14 09:47:41

<< Poza precedenta Poza urmatoare >>

Eveniment

Autor

Data

BUCURESTI - SEMNARE - DECLARATIA UNIVERSITATII BUCURESTI

ROMA - BAZILICA SANTA MARIA MAGGIORE

ROMA

BUCURESTI - CAMPANIA 'ONOR VETERANILOR DE RAZBOI'

JUD. TULCEA - INFRASTRUCTURA

ROMA - PIAZZA DEL POPOLO

ROMA - GALERIA BORGHESE

ROMA - CLADIRI DIN VECINATATEA PARCULUI VILLA BORGHESE

ROMA - CAPELA CERASI

ROMA - SANTA MARIA DI MONTESANTO

ROMA - SANTA MARIA DEI MIRACOLI SI SANTA MARIA DI MONTESANTO

CRAIOVA - BASCHET MASCULIN - UNIVERSITATEA CRAIOVA - FC ARGES PITESTI

MUZEUL VATICAN

BUCURESTI - CONFERINTA DE PRESA - SEBASTIAN BURDUJA

BUCURESTI - ZIUA FORTELOR TERESTRE

TULCEA - EXPOZITIE - 'PASI PRIN ARTA SACRA SPRE PATIMIREA DOMNULUI'

BUCURESTI - CONFERINTA PRESA - NICUSOR DAN

BUCURESTI - CONFERINTA DE PRESA - EMIL IVANESCU - GEORGE TUTA

BUCURESTI - 130 DE ANI DE LA FONDAREA BIBLIOTECII CENTRALE UNIVERSITARE CAROL I

EXPONATE - 1954

ROMA - CLADIRI

ROMA - FORUMUL ROMAN - DEALUL PALATIN

ROMA - COLOSSEUM

ROMA - BASILICA SFINTILOR COSMA SI DAMIAN - OMAGIU PAPA FRANCISC

ROMA - BASILICA SFINTILOR COSMA SI DAMIAN

BUCURESTI - APLICARE TRATAMENT PENTRU COMBATEREA TANTARILOR - COMPANIA MUNICIPALA ECO IGIENIZARE

ROMA - ARCUL LUI CONSTANTIN

BUCURESTI - CAMERA DEPUTATILOR - PLEN

BUCURESTI - PREZENTARE OFICIALA A VIZIUNII 'ROMANIA ONESTA' - NICUSOR DAN

ARAD - POD NOU PESTE MURES

BUCURESTI - 1954

BUCURESTI - MARSUL COMEMORATIV - 'PE URMELE EROILOR ROMANI CAZUTI PE FRONTUL DE VEST - UNGARIA, SLOVACIA, CEHIA'

BUCURESTI - MONUMENTUL EROILOR PATRIEI

ROMA - BISERICA SANT' AGNESE IN AGONE

ROMA - TREPTELE SPANIOLE

ROMA - PANTEON

ROMA - PIAZZA DELLA ROTONDA

ROMA - FONTANA DI TREVI

ROMA - BISERICA SANT' IGNAZIO DE LOYOLA

BUCURESTI - FOTBAL - DINAMO 1948 - UNIVERSITATEA CRAIOVA

BUCURESTI - CATEDRALA SFANTUL IOSIF

BUCURESTI - DECES - PAPA FRANCISC

ROMA - CASTELUL SANT' ANGELO - RAUL TIBRU

ROMA - CASTELUL SANT' ANGELO

ORADEA - FESTIVITATI - ANIVERSARE INSTAURARE ADMINISTRATIE ROMANEASCA

VATICAN - DECES - PAPA FRANCISC

BUCURESTI - FOTBAL - FCSB - CFR 1907 CLUJ

BUCURESTI - HANDBAL - CSM BUCURESTI - TEAM ESBJERG

BUCURESTI - SARBATOAREA INVIERII DOMNULUI - CATEDRALA PATRIARHALA

BUCURESTI - SARBATOAREA INVIERII DOMNULUI - CATEDRALA SFANTUL IOSIF

BUCURESTI - FOTBAL - RAPID BUCURESTI - UNIVERSITATEA CLUJ

BUCURESTI - CIMITIRUL BELLU CATOLIC

BUCURESTI - SARBATOAREA INVIERII DOMNULUI - BISERICA SFANTA TEREZA A PRUNCULUI ISUS

BUCURESTI - CATEDRALA PATRIARHALA

BUCURESTI - CATEDRALA PATRIARHALA - LUMINA SFANTA DE LA IERUSALIM

OTOPENI - LUMINA SFANTA DE LA IERUSALIM

ALEX TUDOR / AGERPRES FOTO

GRIGORE POPESCU / AGERPRES FOTO

MIHAI POZIUMSCHI / AGERPRES FOTO

LUISIANA BIGEA / AGERPRES FOTO

ALEX MICSIK / AGERPRES FOTO

NICOLAE BADEA (C) / AGERPRES FOTO

LAZAR SCHINDERMAN

CRISTIAN NISTOR / AGERPRES FOTO

MARIAN BUGA / AGERPRES FOTO

AGERPRES

EUGENIA PASCA / AGERPRES FOTO

IONUT ANGHEL (C) / AGERPRES FOTO

2020-04-11

$(200414) -- BEIJING, April 14, 2020 (Xinhua) -- A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, capital of China, April 11, 2020. China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday.\r\n The two vaccine candidates were developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm), and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical trials of the two vaccines have started. (Xinhua/Zhang Yuwei)$

$(200414) -- BEIJING, April 14, 2020 (Xinhua) -- A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, capital of China, April 11, 2020. China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday.\r\nThe two vaccine candidates were developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm), and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical trials of the two vaccines have started. (Xinhua/Zhang Yuwei)$

$(200414) -- BEIJING, April 14, 2020 (Xinhua) -- A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, capital of China, April 11, 2020. China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday.\r\n The two vaccine candidates are developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm) and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical trials of the two vaccines have started. (Xinhua/Zhang Yuwei)$

2020-03-16

$(200414) -- BEIJING, April 14, 2020 (Xinhua) -- A staff member tests samples of the COVID-19 inactivated vaccine at a laboratory of Sinovac Biotech Ltd., in Beijing, capital of China, March 16, 2020. China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday.\r\n The two vaccine candidates were developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm), and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical trials of the two vaccines have started. (Xinhua/Zhang Yuwei)$

$(200414) -- BEIJING, April 14, 2020 (Xinhua) -- A staff member tests samples of the COVID-19 inactivated vaccine at a laboratory of Sinovac Biotech Ltd., in Beijing, capital of China, March 16, 2020. China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday.\r\n The two vaccine candidates are developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm) and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical trials of the two vaccines have started. (Xinhua/Zhang Yuwei)$

Conținutul acestui site este proprietatea Agenției Naționale de Presă AGERPRES. Este interzisă republicarea sau redistribuirea conținutului fără menționarea sursei.

Am deja un cont
Creeaza cont

Dacă ai cont gratuit te loghezi cu adresa de email. Pentru a crea un cont gratuit accesează secțiunea “Crează cont”.

Dacă ai cont plătit te loghezi cu username. Pentru a vă crea un cont plătit vă rugăm să contactați:

Direcţia Marketing

Tel: + 40 21 207 61 02

Tel./Fax: + 40 21 207 61 02

E-mail: [email protected]